Display options
Share it on

J Clin Exp Dent. 2019 May 01;11(5):e452-e456. doi: 10.4317/jced.55214. eCollection 2019 May.

Zimmermann-Laband syndrome: Clinical and cytogenetic study in two related patients.

Journal of clinical and experimental dentistry

Sadegh Shirian, Hassan Shahabinejad, Abolfazl Saeedzadeh, Khosrow Daneshbod, Hengameh Khosropanah, Mostafa Mortazavi, Yahya Daneshbod

Affiliations

  1. Department of Pathology, School of Veterinary Medicine, Shahrekord University, Shahrekord, Iran.
  2. Shiraz Molecular Pathology Research Center, Dr Daneshbod Pathology Laboratory, Shiraz, Iran.
  3. Biotechnology Research Inistitute, Shahrekord University, Shahrekord, Iran.
  4. Department of Endodontics, Henry M Goldman School of Dental Medicine, Boston University Boston, MA, USA.
  5. Department of Periodontology, School of Dentistry, Shiraz University of Medical Science, Shiraz, Iran.
  6. Craniomaxillofacial Surgery Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 31275518 PMCID: PMC6599695 DOI: 10.4317/jced.55214

Abstract

BACKGROUND: Zimmermann-Laband Syndrome (ZLS) is an extremely rare autosomal dominant congenital disorder. It is a craniofacial malformation syndrome with predominant intraoral involvement consisting of gingival fibromatosis diffusion in early development. The molecular basis of ZLS is still unknown. Although familial aggregation with different inheritance patterns is detected in ZLS patients, most of the cases are sporadic.

MATERIAL AND METHODS: We report on two sibling patients with clinical manifestations of ZLS. Blood samples of both patients were obtained in EDTA-tubes followed by performing cytogenetic study using Cyto2.7M array. Analysis of the copy number was performed using the Chromosome Analysis Suite Software (version 1.0.1, annotation file na 30, Affymetrix) and interpreted with recourse to the UCSC genome browser (http://genome.ucsc.edu/; Human Mar. 2006NCBI Build 36.1/hg18 assembly).

RESULTS: The array analysis revealed overlapping regions of chromosomal aberrations in both patients. We detected a 258-kb deletion at 3q13.13, a 89-kb duplication at 1q25.2 as well as two 67-kb duplications at 1p12 and 19q12. These altered regions do not contain any known genes and protein-coding sequences.

CONCLUSIONS: In conclusion, the findings of this report revealed new chromosomal aberrations, including a deletion at 3q13.13 and duplications at 1q25.2, 1p12 and 19q12, in the two patients with ZLS. Such findings indicate that whole genome screening for genomic rearrangements is fruitful in typical and atypical patients with ZLS.

Conflict of interest statement

Conflict of interest statement:The authors have declared that no conflict of interest exist.

References

  1. Am J Med Genet. 2001 Jun 15;101(2):100-5 - PubMed
  2. Am J Med Genet A. 2003 Mar 15;117A(3):289-94 - PubMed
  3. Nat Rev Genet. 2006 Jan;7(1):45-54 - PubMed
  4. Am J Med Genet A. 2007 Jan 15;143A(2):107-11 - PubMed
  5. Ultrastruct Pathol. 2006 Nov-Dec;30(6):423-6 - PubMed
  6. Int J Oral Maxillofac Surg. 2010 Sep;39(9):937-41 - PubMed
  7. Hum Mol Genet. 2011 May 15;20(10):1916-24 - PubMed
  8. Dev Cell. 2011 Mar 15;20(3):353-63 - PubMed
  9. Eur J Med Genet. 2012 Jan;55(1):49-55 - PubMed
  10. Curr Probl Pediatr Adolesc Health Care. 2012 Mar;42(3):47-73 - PubMed
  11. Mol Cytogenet. 2013 Aug 06;6(1):30 - PubMed
  12. Eur J Med Genet. 2013 Oct;56(10):570-6 - PubMed
  13. Hum Genet. 1979 Jun 19;49(2):167-73 - PubMed
  14. J Periodontol. 1995 Jan;66(1):75-9 - PubMed
  15. Oral Surg Oral Med Oral Pathol. 1994 Jul;78(1):57-63 - PubMed

Publication Types